Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast Cancer

Condition:   Metastatic Breast Cancer Interventions:   Drug: Sabizabulin;   Drug: Exemestane monotherapy, exemestane plus everolimus, or selective estrogen receptor modulator Sponsor:   Veru Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials